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Introduction:Colorectal cancer is the third major cause of cancer related deaths worldwide. 
Around 5% of these cases are due to Inherited Colorectal Cancer (ICC) associated with 
highly penetrant single-gene mutations. Conventional molecular analysis of patients with 
ICC is well established and usually comprises PCR followed by Sanger sequencing of 
different genes with autosomal dominant inheritance - MLH1, MSH2, MSH6, PMS2 and 
EPCAM-3’ deletions in Lynch syndrome, APC in Familial Adenomatous Polyposis (FAP), or 
the study of an autosomal recessive condition with colorectal polyps associated with 
MUTYH variants. 
As standard molecular methodologies have high costs and are time consuming, they are 
progressively being replaced by Next Generation Sequencing (NGS), which allows the 
analysis of multiple genes simultaneously and with lower costs compared to Sanger 
sequencing.        
In order to validate NGS analysis for a set of genes associated with ICC, we performed 
NGS in 26 DNA samples from patients previously analysed by Sanger sequencing. 
 
Methods: NGS was performed using the Trusight Cancer Sequencing Panel and the MiSeq 
sequencer (Illumina), followed by bioinformatic analysis of the MLH1, MSH2, APC, MUTYH 
and STK11 genes using the MiSeq Reporter, VariantStudio and Isaac Enrichment tools. 
 
Results: Data analysis revealed 77 variants (31 unique, comprising 4 deletions, 1 insertion, 
2 indels and 24 single nucleotide variants). Of these, 76 variants were previously identified 
by Sanger sequencing. NGS produced a false positive result associated with low coverage 
in STK11 (c.375-49G>A).  
 
Discussion: Results obtained by NGS are consistent with Sanger sequencing and showed 
high analytical sensitivity and specificity. Therefore after this initial validation, with high 
repeatability, conventional molecular analysis can be replaced by NGS, allowing us to offer 
the possibility to screen more genes, at lower costs and with a shorter turnaround time. 
